Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$98.98 - $115.74 $8.07 Million - $9.44 Million
81,581 Added 12.18%
751,453 $86.9 Million
Q2 2023

Aug 11, 2023

BUY
$96.34 - $112.38 $50.5 Million - $58.9 Million
523,879 Added 358.84%
669,872 $68.9 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $1.71 Million - $1.8 Million
15,890 Added 12.21%
145,993 $15.9 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $7.41 Million - $13.5 Million
118,791 Added 1050.13%
130,103 $14.8 Million
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $446,083 - $641,036
-7,571 Reduced 40.09%
11,312 $712,000
Q2 2022

Aug 11, 2022

BUY
$79.4 - $116.36 $1.02 Million - $1.5 Million
12,858 Added 213.41%
18,883 $1.53 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $400,297 - $508,639
-4,632 Reduced 43.46%
6,025 $639,000
Q4 2021

Feb 11, 2022

SELL
$98.56 - $119.91 $11,334 - $13,789
-115 Reduced 1.07%
10,657 $1.15 Million
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $1.47 Million - $1.77 Million
-16,004 Reduced 59.77%
10,772 $1.18 Million
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $85,291 - $94,864
989 Added 3.84%
26,776 $2.51 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $119,668 - $159,069
-1,666 Reduced 6.07%
25,787 $2.37 Million
Q4 2020

Feb 25, 2021

BUY
$67.0 - $84.39 $1.76 Million - $2.21 Million
26,206 Added 2101.52%
27,453 $2.01 Million
Q4 2020

Feb 12, 2021

SELL
$67.0 - $84.39 $236,443 - $297,812
-3,529 Reduced 73.89%
1,247 $91,000
Q3 2020

Nov 12, 2020

BUY
$55.23 - $79.93 $263,778 - $381,745
4,776 New
4,776 $373,000
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $614,686 - $953,048
-24,716 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$25.43 - $36.67 $489,883 - $706,410
-19,264 Reduced 43.8%
24,716 $892,000
Q3 2019

Nov 14, 2019

BUY
$23.0 - $27.97 $1.01 Million - $1.23 Million
43,980 New
43,980 $1.2 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.